Health
UK to start HEAL-COVID trial to reduce mortality,re-admission rate among Covid survivors – BusinessLine
This will be carried out in collaboration with the Liverpool Clinical Trials Centre at the University of Liverpool and Wrexham-based clinical trial technology firm…
The United Kingdom is set to initiate a drug trial called HEAL-COVID in an effort to alleviate the mortality rate and readmission cases in patients who have previously been hospitalised with the novel coronavirus.
According to the report by Clinical Trials Arena, data collated by the UK Office for National Statistics indicated that 29 per cent of Covid-19 hospitalised patients were readmitted within six months. While more than 12 per cent died within the same period.
So, the new trial will help…
-
Noosa News18 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News16 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoBrisbane Broncos star Reece Walsh says punching friend in face ‘not a good look’
-
General14 hours agoDairy farmers devastated by floods across parts of New South Wales